Corporate Banner
Satellite Banner
Cell Culture
Scientific Community
Become a Member | Sign in
Home>News>This Article

SLAS Short Courses at ELRIG Drug Discovery 2014

Published: Saturday, June 21, 2014
Last Updated: Saturday, June 21, 2014
Bookmark and Share
SLAS short courses will focus on high content screening, cell-based assays and 3D culture models, and laboratory automation.

The Society for Laboratory Automation and Screening’s highly-experienced and qualified instructors will present three short courses at the ELRIG Drug Discovery 2014 Conference, taking place on September 1 at Manchester, UK.

In an early expansion of their relationship with ELRIG, SLAS will be hosting three short courses on the 1st of September, as part of the Drug Discovery meeting to be held in Manchester, UK (September 2-3).

Bringing this opportunity to Europe will make available to European members a number of the educational offerings that until now have only been available to attendees of the SLAS Annual Meeting.

Respectively, the three short courses will focus on High Content Screening, Cell-based Assays and 3D Culture Models, and Laboratory Automation. In the first course, Dr. Eberhard Krausz and Marc Bickle, PhD, will demonstrate the power of HCS through an overview of the components.

Throughout the second course Dr. Terry Riss and Dr. Jens M. Kelm will show how to establish cell-based assays and determine the latest technological advances in 3D culture technologies.

With the third course, Jonathan Wingfield, PhD, and Malcolm Crook, PhD, will show the possibilities to explore the various options for successfully deploying automation within a laboratory environment.

SLAS was proud to establish the Europe Council in 2013 and promptly started working on its partnerships with existing organizations to bring SLAS science to the broader research community in Europe.

An Education Advisory Committee and an Industry Advisory Committee were founded to complement the SLAS European organization.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Novel Tumor Treatment
In the first published results from a $386,000 National Cancer Institute grant awarded earlier this year, a paper by Scott Verbridge and Rafael Davalos has been published.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Some Gut Microbes May Be Keystones of Health
University of Oregon scientists have found that strength in numbers doesn’t hold true for microbes in the intestines. A minority population of the right type might hold the key to regulating good health.
The Life Story of Stem Cells
A model analyses the development of stem cell numbers in the human body.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Tissue Engineers Recruit Cells to Make Their Own Strong Matrix
Extracellular matrix is the material that gives tissues their strength and stretch. It’s been hard to make well in the lab, but a Brown University team reports new success. The key was creating a culture environment that guided cells to make ECM themselves.
Towards Patient-Specific Drug Screening
A new breakthrough by the 3D stem cell printing team at Heriot-Watt could pave the way to individually tailored drug testing regimes, both reducing the need for animal testing and ensuring that patients receive drugs which are most effective for their individual needs.
Artificial Kidney Research Gets A Boost
Development of a surgically implantable, artificial kidney — a promising alternative to kidney transplantation or dialysis for people with end-stage kidney disease — has received a $6 million boost.
Improving the Efficiency of Red Blood Cell Production
Study points to way of significantly reducing cost of laboratory-produced cells.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos